🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Multi-center, Randomized, Double-blind, Controlled, and Parallel Phase II...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2018-12-28
Trial ID
NCT03650933
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Start Date
2005-09
Trial ID
NCT00101010
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
This phase III trial compares the effects of nivolumab with chemo-immunothe...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2021-10-05
Trial ID
NCT04759586
Treatments Being Tested
This trial is a phase II non-comparative study aimed to determine the feasi...
Status
Completed
Location
A.O. SS. Antonio e Biagio e Cesare Arrigo
Start Date
2009-09-27
Trial ID
NCT00945724
:This is a an open-label, single-arm study to evaluate the efficacy and saf...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07
Trial ID
NCT06474481
Treatments Being Tested
The purpose of this study is to evaluate if zilovertamab vedotin with stand...
Status
Recruiting
Location
USA Mitchell Cancer Institute ( Site 0173)
Start Date
2025-01-27
Trial ID
NCT06717347
This study is a Randomized Phase II Study to Compare Efficacy of CHOP versu...
Status
Unknown
Location
Samsung Medical Center
Start Date
2015-09-23
Trial ID
NCT02445404
Treatments Being Tested
To evaluate the efficacy and adverse effects of lenalidomide combined with ...
Status
Recruiting
Location
Bing Xu
Start Date
2023-11-22
Trial ID
NCT06151080
Treatments Being Tested
Peripheral T cell lymphomas (PTCL) are a rare hematologic disease. Five-yea...
Status
Completed
Location
Spedali Civili di Brescia
Start Date
2006-11
Trial ID
NCT01679860
Treatments Being Tested